Qualigen Therapeutics(US:QLGN) Globenewswire·2025-09-30 10:00Core Insights - Faraday Future Intelligent Electric Inc. is transitioning to a new strategic direction by investing in Qualigen Therapeutics, which is expected to rebrand as CXC10, focusing on crypto and Web3 business [1][2] Investment Details - The total investment in Qualigen Therapeutics amounts to approximately $41 million, with Faraday Future contributing around $30 million and an additional $4 million from YT Jia, the Founder and Global Co-CEO [2] - Other investors include SIGN Foundation, Sequoia Capital, IDG, and Circle [2] Ownership Structure - Following the investment, Faraday Future holds approximately 55% of Qualigen's pro forma common stock, while YT Jia holds about 7%, which he has committed to lock up for two years [3] Strategic Significance - This investment marks a critical milestone in Faraday Future's "Dual-Flywheel & Dual-Bridge" Eco-Strategy, linking electric automotive innovation with crypto and Web3 [3][4] - YT Jia emphasized that this ecosystem aims to create new value for both stockholders and token holders across Faraday Future and CXC10 [4] Company Overview - Faraday Future is a California-based company founded in 2014, focused on disrupting the automotive industry through a user-centric and technology-first approach [4] - The flagship model, FF 91, represents the company's vision for luxury and innovation, with plans to introduce mass production models targeting a broader market [4]